
A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD
Keywords: عارضه جانبی یا عوارض جانبی; AE; adverse event; FSC; fluticasone propionate/salmeterol; ICS; inhaled corticosteroid; LABA; long-acting Ã2-agonist; LAMA; long-acting muscarinic antagonist; MCID; minimal clinically important difference; NNTB; number needed to treat for benefit; SAE; s